CEAPRO INC.: federal grants and contributions: 10 agreements; $2.8M value; 2 departments; 3 programs.
Assay record ASY-CA-11AJUFI0DY · Cite as: Assay Systems, “CEAPRO INC.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/ceapro-inc/
The Pressurized Gas eXpanded (PGX) Technology is a patented platform technology for the generation of fine-structured, open-porous, water-soluble biopolymer carriers for tailor-made bioactive or drug delivery systems. Ceapro will further develop the patented PGX Technology by upgrading the PGX Demonstration Plant and by scaling up the Ceapro impregnation technology to the demonstration scale to generate novel “impregnated Polymer compleX” (iPX) for use as delivery systems. By conducting studies on the iPX generated and modeling processing and equipment costs, Ceapro will continue to progressiv
Ceapro will further develop the Pressurized Gas eXpanded (PGX) platform technology by designing a pharmaceutical PGX processing unit and bioactive impregnation and loading units. These new units will be used to generate active pharmaceutical ingredients for trials required to confirm immune-boosting benefits and address conditions such as pain, depression, sleep disorders, anxiety, and lung fibrosis.
Establish operations in PEI in collaboration with NRC-INH
To hire a project manager
Build a semi-continuous manufacturing facility
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.